- CODEN : IAJPBB
- issn 2349-7750
TITLE:
ADVERSE DRUGS REACTION AND EFFECTIVNESS ON PATIENTS WITH MONITORING AND EVALUATION IN CLINICAL SETTINGS
AUTHORS:
Dr Muhammad Saeed, Tehrim Asif, Dr Osama Aziz
ABSTRACT:
In Clinical practice, this implies having in place a well-organized Pharmacovigilance system. Pharmacovigilance is an important exercise for monitoring of drug related issues after marketed in "real world setting". Pharmacovigilance and all drug related issues are important for everyone whose life is being impacted any way by medical interventions. An organized Adverse Drug Reaction monitoring program is one mechanism to more actively detect ADRs, and consequently positively affect the quality of patient care. To prevent or lessen harm to patients and improving public health, the various mechanisms for evaluating and monitoring the safety of medicines in clinical use are important. Adverse drug reactions (ADRs) have a major impact on public health, reducing patient’s quality of life and imposing a considerable financial burden on the health care systems at a time when many health care systems are under considerable financial strain. All healthcare providers have roles to play in maintaining a balance between a medicine's benefits and risks. Once a drug is available to the public, making a determination about its safety is the shared responsibility of all who are part of the prescribing process, including patients. The role of healthcare professionals is vital in recording and reporting suspected ADRs in order that regulatory agencies are alerted of emerging safety concerns and thereby facilitating timely and appropriate action. Pharmacovigilance is an important exercise for monitoring of drug related issues after marketed in “real world setting”. Pharmacovigilance and all drug related issues are important for everyone whose life is being impacted any way by medical interventions. This paper unfolds very aspects of adverse drug reaction monitoring and evaluation in clinical settings. Key words: Pharmacovigilance, Drug, Adverse drug reactions,
FULL TEXT
<Approved Journal
NLM ID:101711216 [Serial]
Included in EuroPub database
ICV 2015 - 61.16
Indexed In
S.J Impact Factor:7.157
cosmos Impact Factor:4.153
ICMJE Recommendations
IP Indexing Impact Factor: 2.76
Cover Page
